Amantadine and rimantadine for influenza A in adults.

Author: DemicheliV, Di PietrantonjC, JeffersonT, RivettiD

Paper Details 
Original Abstract of the Article :
BACKGROUND: Amantadine hydrochloride and rimantadine hydrochloride have antiviral properties, but they are not widely used due to a lack of knowledge of their potential value and concerns about possible adverse effects. OBJECTIVES: The objective of this review was to assess the efficacy, effectiven...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068158/

データ提供:米国国立医学図書館(NLM)

Amantadine and Rimantadine: Antiviral Agents for Influenza A

The fight against influenza is a constant battle, with researchers continuously seeking new and effective treatments. This study delves into the world of antiviral agents, specifically amantadine and rimantadine, exploring their potential as treatments for influenza A. The authors conducted a comprehensive review of existing research, analyzing the efficacy, effectiveness, and safety of these drugs in healthy adults. Their findings reveal that both amantadine and rimantadine demonstrate effectiveness in reducing the severity and duration of influenza A symptoms, with amantadine showing a slightly greater impact. However, the study highlights the importance of carefully considering potential side effects, particularly gastrointestinal and central nervous system adverse reactions.

A Balanced Perspective on Antiviral Therapy

The study offers a nuanced perspective on the use of amantadine and rimantadine for influenza A. While both drugs demonstrate efficacy, the researchers emphasize the importance of weighing potential benefits against risks. The study suggests that these drugs should be reserved for cases where other treatment options have failed.

Staying Informed and Safe

This research highlights the need for informed decision-making when it comes to medication. It's essential to consult with a healthcare provider to determine the best course of action for influenza A, considering both the potential benefits and risks of antiviral treatments.

Dr. Camel's Conclusion

The desert of viral infections can be a treacherous landscape, but researchers are constantly working to develop tools to combat these threats. This study provides valuable insights into the potential of amantadine and rimantadine, reminding us that the pursuit of knowledge is a continuous journey. Like a seasoned camel traversing a vast desert, we must approach medical decisions with a combination of caution and informed understanding.

Date :
  1. Date Completed 2006-06-15
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

16625539

DOI: Digital Object Identifier

PMC7068158

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.